Novo Nordisk Financial Market Data
| Last Close 25-Sep-2008 |
$54.62 |
Price/ Sales Ratio |
0.21 |
| 52-Week High |
$73.73 |
Price/ Book Ratio |
0.27 |
| 52-Week Low |
$49.91 |
Price/ Earnings Ratio |
-- |
| 60-Month Beta |
0.5 |
Price/ Cash Flow Ratio |
0.88 |
| Market Cap (mil.) |
-- |
Return on Assets |
19.5% |
| Shares Outstanding (mil.) |
-- |
Return on Equity |
29.2% |
| Dividend Rate |
0.68 |
Current Ratio |
2.28 |
| Dividend Yield |
68.0% |
Long-Term Debt/Equity |
0.04 |
| # of Institutional Holders |
247 |
% Owned by Institutions |
5.0% |
| Latest Short Interest Ratio |
1.44 |
Latest Net Insider Transactions |
-- |
| Revenue Growth |
20.5% |
55.2% |
0.0% |
| EPS Growth |
0.0% |
0.0% |
0.0% |
| Dividend Growth |
9.5% |
119.4% |
260.6% |
This data is provided as per license from EDGAR Online
